List of MolMed patents

List of MolMed patents

List of Coupons.com patents

List of Rogers Communications patents

List of Asahi Kasei patents

CEOs of nanobiotechnology companies

List of funding rounds for Qd Vision, Inc.

Patents where

Current Assignee

Name

is

MolMed

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9441245 Stable production of lentiviral vectors	Patent 9441245 was granted and assigned to MolMed on September, 2016 by the United States Patent and Trademark Office.		MolMed		United States Patent and Trademark Office	9441245	September 13, 2016
	‌ US Patent 9133481 Semi-stable production of lentiviral vectors	Patent 9133481 was granted and assigned to MolMed on September, 2015 by the United States Patent and Trademark Office.		MolMed		United States Patent and Trademark Office	9133481	September 15, 2015
	‌ US Patent 8357788 Thymidine kinase	Patent 8357788 was granted and assigned to MolMed on January, 2013 by the United States Patent and Trademark Office.		MolMed		United States Patent and Trademark Office	8357788	January 22, 2013
	‌ US Patent 7413733 Antigen transduced T cells used as a delivery system for antigens	Patent 7413733 was granted and assigned to MolMed on August, 2008 by the United States Patent and Trademark Office.		MolMed		United States Patent and Trademark Office	7413733	August 19, 2008
	‌ US Patent 10155052 Thymidine kinase	Patent 10155052 was granted and assigned to MolMed on December, 2018 by the United States Patent and Trademark Office.	MolMed	MolMed		United States Patent and Trademark Office	10155052	December 18, 2018
	‌ US Patent 9782496 Immunoconjugates for the treatment of tumours	Patent 9782496 was granted and assigned to MolMed on October, 2017 by the United States Patent and Trademark Office.	MolMed	MolMed		United States Patent and Trademark Office	9782496	October 10, 2017
	‌ US Patent 9119886 Immunoconjugates for the treatment of tumours	Patent 9119886 was granted and assigned to MolMed on September, 2015 by the United States Patent and Trademark Office.		MolMed		United States Patent and Trademark Office	9119886	September 1, 2015
	‌ US Patent 8642311 Thymidine kinase	Patent 8642311 was granted and assigned to MolMed on February, 2014 by the United States Patent and Trademark Office.		MolMed		United States Patent and Trademark Office	8642311	February 4, 2014
	‌ US Patent 10314925 Thymidine kinase	Patent 10314925 was granted and assigned to MolMed on June, 2019 by the United States Patent and Trademark Office.	MolMed	MolMed		United States Patent and Trademark Office	10314925	June 11, 2019
	‌ US Patent 8912152 HIV vif mutants	Patent 8912152 was granted and assigned to MolMed on December, 2014 by the United States Patent and Trademark Office.		MolMed		United States Patent and Trademark Office	8912152	December 16, 2014

10 results

0 selected

10 results

0 selected